Fundraising FoxNitrome Biosciences
Jackson, US · Delaware corporation · 3 known investors
Find your way into Nitrome Biosciences
Sign up to see every warm intro you have to Nitrome Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nitrome Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
IG
Irene Griswold-PrennerFounder
Board
Investors · 3
SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M
How we know: SV Health Investors's portfolio page · Not right? Tell us
Dementia Discovery FundreportedLondon
How we know: funding news · Not right? Tell us
Sofinnova PartnersreportedParis · $540K – $27M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18.9M disclosed across 5 rounds · 2018–2020
▶$17.1MraisedApr 2020 · 18 investors · BiotechnologyRule 506(b)
▶$17.1MraisedApr 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Margarita ChavezDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Henrijette RichterDirector
- Jonathan BehrDirector
- Offering amount
- $47.5M
- Amount sold
- $17.1M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJul 2019 · 9 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zach HallDirector
- Ephraim HellerDirector
- William McDowellDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Regis KellyDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedJan 2019 · 8 investors · BiotechnologyRule 506(b)
▶$400KraisedJan 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Regis KellyDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Zach W. HallDirector
- William McDowellDirector
- Ephraim HellerDirector
- Offering amount
- $1.6M
- Amount sold
- $400K
- Minimum investment
- $10K
- Proceeds to insiders
- $14.5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$750KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Irene Griswold-PrennerExecutive Officer
- Offering amount
- $2.4M
- Amount sold
- $750K
- Minimum investment
- $10K
- Proceeds to insiders
- $250K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$104.6KraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$104.6KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Regis KellyDirector
- Ephreim HellerDirector
- Zach W. HallDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Offering amount
- $104.6K
- Amount sold
- $104.6K
- Minimum investment
- $900
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Nitrome Biosciences?
- Nitrome Biosciences was founded by Irene Griswold-Prenner.
- Who are Nitrome Biosciences's investors?
- Nitrome Biosciences's investors include SV Health Investors, Dementia Discovery Fund, Sofinnova Partners.
- How much funding has Nitrome Biosciences raised?
- Nitrome Biosciences has disclosed $18.9M raised across 5 rounds.
- Where is Nitrome Biosciences headquartered?
- Nitrome Biosciences is headquartered in Jackson, US.